FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

70961008: Neomycin sulfate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
117867011 Neomycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
501730016 Neomycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
811074015 Neomycin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
117867011 Neomycin sulfate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
117867011 Neomycin sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
501730016 Neomycin sulphate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
501730016 Neomycin sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
811074015 Neomycin sulfate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
811074015 Neomycin sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
827531000172117 sulfate de néomycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50015211000188114 néomycine sulfate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
827531000172117 sulfate de néomycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50015211000188114 néomycine sulfate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin sulphate Is a Neomycin-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulphate Is a Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulphate Is a Neomycin false Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulphate Is a Substance with aminoglycoside structure and antibacterial mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulphate Is modification of (attribute) Neomycin true Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulphate Has disposition Antibacterial (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Neomycin sulfate [systemic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate 5 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate 0.5% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate 5 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate [ear] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate 25 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neo-tabs 500mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Mycifradin 125mg/5mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neo-fradin 125mg/5mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Chlorhexidine hydrochloride+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Colistin sulfate + hydrocortisone acetate + neomycin sulfate 0ns/10mg/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulphate 1mg/3.5mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Dexamethasone sodium phospha + neomycin sulphate 0ns/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Colistin sulfate + hydrocortisone acetate + neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone acetate+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
médicament contenant dexaméthasone et néomycine et polymyxine B The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dexamethasone sodium phosphate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
allergie au sulfate de néomycine Causative agent (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Chlorhexidine hydrochloride and neomycin sulfate adverse reaction Causative agent (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to chlorhexidine hydrochloride and neomycin sulfate Causative agent (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasol propionate+neomycin sulfate+Nystatin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing clobetasone butyrate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
allergie au sulfate de néomycine Causative agent (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 500 mg oral tablet Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 0.5% conventional release eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept)
Neomycin sulfate 500 mg oral tablet Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 25 mg/mL oral solution Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 25 mg/mL oral solution Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Neomycin sulfate 5 mg/g eye ointment Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 5 mg/g eye ointment Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 0.5% conventional release eye drops Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 0.5% conventional release eye drops Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 5 mg/mL eye drops Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 5 mg/mL eye drops Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has precise active ingredient False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Has basis of strength substance (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to chlorhexidine hydrochloride and neomycin sulfate Causative agent (attribute) False Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release ear solution (clinical drug) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 5 mg/mL and prednisolone sodium phosphate 5 mg/mL ear and eye drops Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Neomycin sulfate 5 mg/mL and prednisolone sodium phosphate 5 mg/mL ear and eye drops Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye drops (clinical drug) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream Has basis of strength substance (attribute) True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder Has precise active ingredient True Neomycin sulphate Inferred relationship Existential restriction modifier (core metadata concept) 3

Page 1 of 2 End

This concept is not in any reference sets

Back to Start